Judaya, Carlito C.

HRN: 26-79-24  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2025
CEFTAZIDIME 1GM (VIAL)
03/27/2025
04/03/2025
IV
2gms
Q8
CAP HR
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Cardiovascular    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes